The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy
NCT01910532
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Sponsor discontinued the research
Conditions
Hypertension
Interventions
DRUG:
Clevidipine
Sponsor
Mario Ammirati